CorNova (Burlington, MA) a development-stage medical device company focused on stent placement and non-drug-eluting stents designed to reduce restenosis and acute thrombosis, closed a $2.5M Series B financing. Participatns were not identified.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.